Medable

Company profile

About Medable

Medable Inc. is a leading technology platform for AI-powered clinical development that transforms how pharmaceutical companies, biotechs, and CROs design and execute clinical trials. The company's platform combines agentic AI with unified clinical workflows to accelerate trial startup, enrollment, and conduct. Medable's core offerings include eCOA+ (electronic Clinical Outcome Assessments), Total Consent (eConsent solutions), and an Agent Platform featuring purpose-built AI agents for clinical monitoring, trial master file management, digital data flow, and principal investigator support. The platform enables sponsors to build studies up to 35 times faster using AI-assisted configuration tools and maintains over 90% participant adherence across trials. Medable specializes in therapeutic areas including oncology, vaccines, and cardiometabolic conditions, having delivered 89+ oncology studies across 55+ countries and supported 32+ vaccine trials with 86,000+ participants globally. The company serves mid-to-large pharmaceutical companies, emerging biopharma, and contract research organizations with solutions that span the entire clinical trial lifecycle. Medable's vision of '1:1:1' aims for one-day study start, one-day patient enrollment, and one-year study conduct, representing a fundamental shift in clinical development timelines. The platform is built with GxP compliance, regulatory requirements, and audit readiness as foundational elements, ensuring every automated action is traceable, explainable, and human-supervised.

Company description · Medable official website